Merck (NYSE:MRK) is doubling down on China's biotech boomthis time with a $2 billion licensing deal for a potential blockbuster heart drug from Jiangsu Hengrui Pharmaceuticals. The deal gives ...

This year's two sessions is a reconfirmation of the confidence that Merck has in China because the Chinese government has set ...

This year's two sessions is a reconfirmation of the confidence that Merck has in China because the Chinese government has set the economic growth target at 5 percent, focusing more on innovation ...

Merck (NYSE:MRK) is doubling down on China's biotech boomthis time with a $2 billion licensing deal for a potential blockbuster heart drug from Jiangsu Hengrui Pharmaceuticals. The deal gives Merck ...

He was also upbeat about a Chinese program to encourage American college students to visit China. And yet, Chen noted, the White House referred to China as an “adversary” last month in a ...

The moves in China by the likes of Merck also come as the industry stares down a wave of generic drugs this year that has made the issue of securing new candidates all the more pressing.

Chief Adviser Yunus returns after four-day China visit As he embarked on his return journey, Yunus said in China that it is “important” for his country to see Beijing as a good friend.

Merck (NYSE: MRK) is a top healthcare company ... Demand has, however, been a bit underwhelming of late, particularly in China, which is a key market for the vaccine. But if you believe the ...

China maintains its right to defend its “sovereignty” and has characterized the Philippines as provocative. When asked about Hegseth’s Manila visit in a regular news briefing Friday ...

Hengrui Pharma signed the agreement with Merck (NYSE: MRK) — known as MSD outside of the United States and Canada — for HRS-5346, its investigational oral small molecule Lipoprotein (a), or Lp (a), ...

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding the MSD Greater China region. Hengrui Pharma will ...